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Polyketides represent a diverse
family of natural products syn-
thesized by bacteria, fungi,
plants, and animals, and have
found extensive use as pharma-
ceuticals (e.g. , antimicrobials, an-
tivirals, and antineoplastics) and
other commercially important
products (e.g. , food ingredients,
nutraceuticals, and pigments).[1–4]
Although naturally occurring
polyketides have diverse struc-
tures, the majority are produced
by three broad classes of polyke-
tide synthases (PKSs) that share
a common mechanism involving
sequential decarboxylative con-
densation reactions to form CC
bonds between simple carboxyl-
ic acid extender units and the
nascent acyl chain.[4] Whereas
the vast majority of studies have
focused on the modular and iter-
ative type I and iterative type II
PKSs, recent work has led to a
new appreciation for the homo-
dimeric type III PKSs[5–7] that give
rise to a range of aromatic com-
pounds, including flavonoids
and chalcones as well as some a-pyrone acylketides. Here we
report the potential for removing type III PKSs from their natu-
ral biosynthetic context and adapting them to accept unnatu-
ral substrates in order to access a more structurally diverse
chemical space. In addition, we show the remarkable ability of
one Streptomyces coelicolor type III PKS to accept efficiently an
acyl-ACP as its starter unit.
Pyrone-containing natural products exhibit a wide range of
biological activities; this is a consequence of their structural di-
versity (Scheme 1). Pyrones are synthesized by PKSs through
successive condensations of malonyl-CoA derived C2 units fol-
lowed by lactonization. The fungal metabolites fusapyrone[8]
and D8646-2-6[9] are most likely derived from iterative type I
PKSs, and enterocin[10] is produced by a type II PKS. On the
other hand, germicidins A, B, and C,[11] as well as the signaling
molecule precursor, phlorocaprophenone,[12] have been shown
to be produced by PKS proteins from the type III family.
Type III PKSs differ from type I and type II PKSs in several key
aspects. First, they function as homodimers in which each sub-
unit consists of a single domain of ~40 kDa. Additionally,
rather than utilizing substrates that are covalently linked to
acyl-carrier proteins (ACP), they are thought to mainly use acyl-
coenzyme A (acyl-CoA) thioesters as substrates. Two notable
exceptions have recently been reported and will be discussed
below. Furthermore, the same active site that catalyzes the
Claisen condensations is also responsible for loading of the
starter unit and cyclizing the polyketide intermediate. Finally,
type III PKSs have demonstrated a relaxed substrate specificity,
and have been shown to convert non-native acyl-CoA sub-
strates to pyrones in vitro.[13–15] Taken together, these character-
istics make type III PKSs ideal candidates for engineering of ar-
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Scheme 1. Structures of a-pyrone metabolites and closely related molecules from type I, type II, and type III
polyketide synthases.
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tificial, enzyme-based systems for the creation of diverse
pyrone-containing small molecules.
Streptomyces coelicolor hosts a wide array of genes that are
homologous to various types of natural-product biosynthetic
enzymes, including type I modular PKSs, type II PKSs, type III
PKSs, nonribosomal peptide synthases, sesquiterpene synthas-
es, siderophore synthetases, among others.[16] Based upon pro-
teins predicted to be encoded by its genome, S. coelicolor is
thought to have the genetic capacity to produce more than 20
natural products.[17] Though some of the physiological roles for
these gene clusters remain unclear, we sought to harness the
rich potential of the type III PKSs to develop a method to
create novel small molecules. Of the three type III PKS clusters
found in S. coelicolor (see the Supporting Information), tetrahy-
droxynaphthalene synthase (THNS) has been extensively stud-
ied; its homologue from Streptomyces griseus was the first bac-
terial type III PKS to be identified and biochemically character-
ized.[18, 19] THNS is known to catalyze the sequential decarboxy-
lative condensation, intramolecular cyclization, and aromatiza-
tion of an oligoketide derived from five units of malonyl-CoA
to give 1,3,6,8-tetrahydroxynaphthalene (THN), which sponta-
neously oxidizes to flaviolin. In addition, the kinetics of THN
formation and the crystal structure of this enzyme have been
reported.[20,21] Based on previous studies that revealed the sub-
strate tolerance of THNS, we explored this enzyme for the bio-
synthesis of novel small molecules.[15,22] However, THNS prefers
malonyl-CoA as a building block for both initiation and exten-
sion, which means that pyrone formation is secondary to fla-
violin synthesis. Hence, we sought other type III PKSs the start-
er unit specificity of which were orthogonal to extender unit
preference and would, therefore, not compete with malonyl-
CoA.
At the outset of our investigations, proteins from two type III
PKS genes, sco7221 and sco7671 had not yet been associated
with the production of known metabolites. Recently, the role
for SCO7221 was reported and the type III PKS was designated
Gcs to reflect its role in generating the germicidin series of nat-
ural product pyrones (Scheme 1).[11] The physiological role for
SCO7671 and its corresponding metabolite remain unidenti-
fied. In this study, we describe our investigation of the func-
tion, substrate specificity, and product profile of Gcs and
SCO7671, two type III PKSs from S. coelicolor, including the no-
table ability of Gcs to accept an acyl-ACP as a starter unit.
Though the number of characterized bacterial type III PKSs
continues to grow, there are still numerous family members
with potentially novel activities yet to be described.[7] As ex-
pected, the amino acid sequence similarities of bacterial type
III PKSs compared to other bacterial and plant chalcone-like
synthases were found to be in the 20–35% range (see the Sup-
porting Information). Analysis of these sequences revealed that
SCO7671 is most closely related to a family of mycobacterial
type III PKSs that includes PKS11 and PKS10. PKS11 has been
studied in vitro, and found to produce 6-alkyl-4-hydroxy-2-py-
rones in the presence of fatty acyl-CoAs.[23] PKS10 has been
shown to play an as yet unidentified role in the biosynthesis of
the cell wall lipid component dimycocerosyl phthiocerol—an
important factor in the pathogenesis of Mycobacterium tuber-
culosis.[24] The only other known enzyme with significant simi-
larity to Gcs was found in the pathogen Streptomyces scabies
(http://www.sanger.ac.uk), which showed 86% sequence iden-
tity at the amino-acid level. However, no physiological or meta-
bolic role has been reported for this type III PKS homologue.
To confirm the presence of type III polyketide synthase cata-
lytic activity in the purified proteins, both type III PKS genes
sco7221 (Gcs) and sco7671 (SCO7671) were cloned into the
pET-28b(+) expression vector, and the expressed proteins were
purified in one step on Ni–NTA resin. Elution of the individual
polypeptides from a size-exclusion column (see the Supporting
Information) was consistent with a dimeric form for both en-
zymes. Next, acyl-CoA substrates were tested for their ability to
function as priming units in the presence of malonyl-CoA ex-
tender units, and the yields of the individual reactions were
determined (Scheme 2 and Table 1). For these studies, acyl-
CoA (0.2 mm) starter unit, [2-14C]malonyl-CoA (0.5 mm), and
enzyme (4 mm) were incubated for 90 min at 30 8C before ex-
traction with ethyl acetate followed by separation and visuali-
zation by using radio-TLC.
UV spectroscopy and LC-ESI mass spectrometry results sug-
gested the triketide pyrone product structures 2a–2p
(Scheme 2). Rigorous structural identification was performed
for specific compounds by using NMR spectroscopy (see the
Supporting Information). Pyrones with aliphatic C6-substitu-
ents exhibited characteristic UV absorption at 285–290 nm; the
absorption peak shifted to 318 nm for the phenylpyrone, 2 i. In
SCO7671-catalyzed reactions that were primed with the long-
Table 1. Product yields for Gcs- and SCO7671-catalyzed reactions, in
vitro.
Percentage yield[a]
Starter unit Pyrone Gcs SCO7671
1a acetoacetyl-CoA 2a 70–91 44–54
1b acetyl-CoA 2b – trace
1c propionyl-CoA 2c 1.2–1.8 4.2–7.4
1d butyryl-CoA 2d 11–14 40–45
1e hexanoyl-CoA 2e 36–40 55–70
1 f octanoyl-CoA 2 f 1.0–1.1 26–34
1g decanoyl-CoA 2g – 2.2–5.5
3g 0.9–2.1
1h lauroyl-CoA 2h – trace
3h 0.9–3.3
1i benzoyl-CoA 2 i – 25–27
1j iso-butyryl-CoA 2 j – 13–17
1k malonyl-CoA 2k – trace
1l ACHTUNGTRENNUNG(R,S)-3-hydroxy-3-methylglutaryl-CoA 2 l – –
1m ACHTUNGTRENNUNG(R,S)-b-hydroxybutyryl-CoA 2m 4.5–8.9 0.5–2.6
1n ACHTUNGTRENNUNG(R,S)-b-hydroxybutyryl-SNAc 2n 1.9–2.0 0.4–0.5
1o (R)-b-hydroxybutyryl-SNAc 2o 1.0–1.1 0.6–0.6
1p ACHTUNGTRENNUNG(3R,2S)-hydroxy-2-methylvaleryl-SNAc 2p 0.9–1.3 –
1q ACHTUNGTRENNUNG(3R,2R)-hydroxy-2-methylvaleryl-SNAc 2q – –
[a] The values shown are the ranges from at least two experiments. Yields
are relative to the amount of starter unit and were determined by quan-
tification of the amount of incorporated [14C]-label and corrected for the
number of extensions; yields refer to the triketide pyrones 2a–q unless
indicated otherwise.
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chain fatty acyl-CoA compounds, 1g and 1h, the correspond-
ing tetraketide pyrones, 3g and 3h, were formed in addition
to the triketide pyrone products, 2g and 2h. This assignment
was based on UV absorption characteristics and the relative re-
tention times on TLC and HPLC in comparison to previously
characterized tri- and tetraketide pyrones.
Interestingly, no products (or only trace amounts) were ob-
served upon incubation of enzyme with malonyl-CoA (1k)
alone. The preferred starter unit substrates for Gcs were C4–C6
acyl-CoA esters, and the 3-oxo compound acetoacetyl-CoA
gave the highest yield at 80% (Table 1). SCO7671 exhibited a
broader substrate profile than Gcs and efficiently converted
substrates with chain lengths between C4 and C8 to a series of
pyrones 2d–f. One striking difference in acyl chain specificity
was found in the utilization of the a-branched acyl substrates
iso-butyryl- and benzoyl-CoA, which were converted by
SCO7671 in good yields but were not accepted by Gcs. The
26% product yield for phenylpyrone 2 i, which was obtained
with SCO7671, is remarkable given that THNS processes benzo-
yl-CoA 1 i inefficiently.[15, 18]
As with other PKSs,[25] Gcs and SCO7671 were also capable
of utilizing N-acetylcysteamine (SNAc) thioesters in place of
CoA derivatives. As shown through the comparison of racemic
b-hydroxybutyryl-CoA (1m) with its SNAc equivalent (1n), the
yields were between two- and tenfold lower for the latter with-
out an effect on the product profile. The capability of employ-
ing SNAc esters as substrates facilitates the expansion of the
starter unit repertoire as they are readily accessible by using
synthetic or enzymatic approaches.[26–28]
Tetraketide pyrones (3g and 3h) were only observed when
SCO7671 was primed with decanoyl- or lauroyl-CoA. This ob-
servation has been noted in at least two other bacterial type III
PKSs. When the substrate specificity of PKS18 from M. tubercu-
losis was probed, it was found that larger substrates could give
rise to a preference for additional rounds of extension.[29] In ad-
dition, the octanoyl-CoA primed THNS reaction resulted in a
hexaketide product.[18] Access to an alternative binding tunnel
that can accommodate long fatty acid chains has been sug-
gested as an explanation for these data. Evidence for this
tunnel can be seen in the PKS18 crystal structure,[29] and ap-
pears to result from subtle changes near the substrate-binding
site. Sequence similarities are too low to accurately predict an
analogous tunnel in SCO7671, but one would expect its pres-
ence based upon current biochemical data.
From the results described above it is evident that Gcs and
SCO7671 type III PKSs can accept acyl-CoA starter units, extend
them by one to three malonyl-CoA equivalents, and cyclize the
linear polyketide to form pyrone natural products. However,
recent reports led us to challenge the traditional view that all
type III PKSs must exclusively use acyl-CoA starter units. Based
upon sequence alignments, Austin and Noel suggested that
perhaps bacterial type III PKSs, and not plant type III PKSs,
might be able to accept starter units from ACPs.[5] Evidence for
this prediction was obtained when the structure of a C-termi-
nal type III PKS domain from Dictyostelium discoideum was re-
ported.[12] In this system, the iterative type III PKS (Steely 1) is
comprised of a much larger polypeptide that includes up-
stream type I fatty acid synthase (FAS) domains. One further
suggestion came from the recent work of Challis and col-
ACHTUNGTRENNUNGleagues on the physiological role for Gcs.[11] Specifically, a fatty
acid metabolite, 3-oxo-4-methyl-pentyl-ACP was proposed as
the priming unit due to the role of this precursor as an inter-
mediate in fatty-acid biosynthesis. This complex starter unit is
extended only once by Gcs in vivo with an ethylmalonyl thio-
ester to produce germicidin. It is possible that these two PKSs
might accept either the ACP-tethered acyl chain or the acyl-
CoA after offloading from the ACP. We, therefore, sought defin-
itive biochemical evidence for acyl-ACP transfer in type III PKSs.
We designed a series of experiments to assess the ability of
Gcs and SCO7671 to accept an acyl starter unit directly from a
charged ACP. In particular, we chose a test set of four discrete
ACPs that varied with respect to their biosynthetic context,
and would be amenable to expression in E. coli in apo form. As
hexanoyl-CoA gave good conversion efficiencies with both Gcs
and SCO7671 S. coelicolor type III PKSs, this starter unit was
used as a model substrate for the acyl-ACP transfer reactions.
ACPs require post-translational modification of a conserved
serine residue with the coenzyme A-derived phosphopante-
theinyl (P-pant) group in order to form the requisite acyl-thio-
ester linkage. The ACP synthases Sfp and Svp (from surfactin
biosynthesis in Bacillus subtilis and bleomycin biosynthesis in
Streptomyces verticillus ATCC15003, respectively) have been
shown to convert a variety of noncognate ACPs from secon-
dary metabolism to the holo form, both in vivo and in
vitro.[30,31] Furthermore, these enzymes are able to convert apo-
ACPs directly to their acylated holo forms in vitro when acyl-
Scheme 2. Reaction scheme for the formation of tri- and tetraketide
pyrones; see Table 1 for R groups.
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CoA instead of coenzyme A is used as substrate. Conversion of
the four apo-ACPs MmcB (mitomycin biosynthesis),[32] TcmM
(tetracenomycin biosynthesis),[33] Otc (oxytetracycline biosyn-
thesis),[34] and SCOACP (sco0549, lipid metabolism)[16] into their
acylated holo forms (acyl-ACP) was rigorously established by
using electrospray mass spectrometry (see the Supporting In-
formation). Following in vitro acylation, unreacted hexanoyl-
CoA was eliminated by utilizing the His-tags on the ACPs. After
elution from the resin, proteins were dialyzed into Bis-Tris
buffer at pH 6.8 to limit hydrolysis of the thioester bond.
MmcB and Otc were efficiently converted to their correspond-
ing hexanoyl holo forms by using Sfp, whereas TcmM and
SCOACP were poor substrates for this ACP synthase, and only
yielded 10% and 30% acyl-ACP, respectively. However, when
using Svp as the phosphopantetheinyl transferase all apo-ACP
was converted to acyl-ACP. ESI-MS enabled estimation of the
relative abundance of acylated species (see the Supporting
Information).
ACP mutants were prepared by using primer-directed muta-
genesis to replace the active-site serine (phosphopantetheine
attachment site) with alanine. This ensured that transfer would
result directly from the acyl-ACP
and not unreacted acyl-CoA
from the holo-ACP reaction.
These ACP ACHTUNGTRENNUNG(Ser!Ala) mutants
underwent mock phosphopante-
theine modification in parallel to
their corresponding native ACPs,
which served as negative con-
trols. Purification of the acyl-
ACPs and ACP ACHTUNGTRENNUNG(Ser!Ala) mu-
tants was performed by binding
the His-tagged fusion proteins
to Ni–NTA resin and thoroughly
washing the resin with buffer. It
was found that 50-resin volumes
of wash buffer were required to
eliminate carry-over of hexanoyl-
CoA into the type III PKS assay
as determined by the presence
or absence of product in the
ACP ACHTUNGTRENNUNG(Ser!Ala)-mutant contain-
ing reactions.
To perform the type III PKS
conversion assay, equal amounts
of hexanoyl-ACP, ACP ACHTUNGTRENNUNG(Ser!Ala)
mutant, or hexanoyl-CoA (10 mm)
were incubated with Gcs or
SCO7671 (2 mm) in the presence
of [14C]malonyl-CoA (80 mm) as
extender unit. Reaction products
were analyzed by using radio-
TLC (Figure 1). A single product
corresponding to 2e was ob-
served in all hexanoyl-ACP
primed reactions. For SCO7671
the amount of pyrone formed
corresponded to approximately 10% of the amount obtained
with hexanoyl-CoA. No significant difference between the indi-
vidual ACPs was observed. In contrast, Gcs converted the hexa-
noyl-ACPs relatively efficiently. The reaction with the highest
yield was with hexanoyl-TcmM as substrate and resulted in ap-
proximately 50% pyrone compared to the hexanoyl-CoA-
primed reaction. The other tested hexanoyl-ACPs resulted in
approximately 25% yield in pyrone compared to hexanoyl-
CoA. A complete biochemical study comparing the Km and kcat
values between acyl-CoA and acyl-ACPs has yet to be complet-
ed for the hexanoyl series of starter units with these enzymes.
However, to the best of our knowledge, this is the first time
that acyl transfer from ACP to type III PKS has been demon-
strated in vitro. Furthermore, the ability of the type III PKSs
used in this work to perform thioacyl transfer provides evi-
dence that the enzyme is capable of accepting very large mac-
romolecular substrates as acyl carriers.
In conclusion, we selected type III PKSs as the architecturally
most simple system capable of forming a pyrone functional
group to investigate the potential for removing these enzymes
from their natural biosynthetic context and adapting them to
Figure 1. A) ACP-transfer assays: reaction mixtures contained starter ACP or starter CoA (10 mm), [2-14C]malonyl-
CoA (80 mm), type III PKS (2 mm), and were incubated for 40 min before reactions were stopped by addition of
hydrochloric acid. B) Radio-TLC analysis of products obtained from Gcs- or SCO7671-catalyzed reactions. Relative
to hexanoyl-CoA, percentage conversions for Gcs after 40 min incubation were: Otc 25%, MmcB 25%, TcmM 50%,
SCOACP 25%, CoA 100%.
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accept unnatural substrates. Studies on the substrate tolerance
and product profile of two type III PKSs (Gcs and SCO7671)
from S. coelicolor revealed that both enzymes are capable of
converting a range of substrates into a-pyrones with moderate
to good yields. Our search for additional methods to deliver
complex starter units has provided definitive biochemical evi-
dence that Gcs can utilize charged ACPs as substrates. To our
knowledge, this is the first direct demonstration that acyl-ACPs
are suitable for presenting starter units to type III PKSs, and it
is consistent with recent in vivo studies[11, 12] that suggest that
acyl-ACP transfer occurs in select prokaryotic and eukaryotic
type III PKS systems. Futhermore, it is notable that in vitro Gcs
is capable of utilizing acyl groups carried by either the small
molecule, acyl-CoA, or the small protein, ACP.
Experimental Section
Bacterial strains and chemicals : [2-14C]Malonyl-CoA
(55 mCimmol1) was obtained from American Radiolabeled Chemi-
cals, Inc. (St. Louis, MO, USA) and was diluted with unlabeled ma-
lonyl-CoA (10 mm) to give a concentration of 5 mm for use in all
reactions. All acyl-CoAs were purchased from Sigma. All reagents
were used without further purification. E. coli strains DH5a and
BL21ACHTUNGTRENNUNG(DE3) from Novagen were used as hosts for cloning and gene
expression, respectively.
Acylation of ACPs : A typical reaction mixture contained apo-ACP
or ACP ACHTUNGTRENNUNG(Ser!Ala) mutant (30 mm), Sfp (1 mm for MmcB and Otc) or
Svp (1 mm for TcmM or scoACP), hexanoyl-CoA (0.3 mm), MgCl2
(10 mm), Tris buffer (0.1m, pH 8.1) in a total volume of 0.6 mL.
After incubation at 30 8C for 45 min Ni–NTA (60 mL) resin was
added, and the proteins were allowed to bind at 4 8C for 30 min
with gentle agitation. The resin was washed with lysis buffer
(3.2 mL; 250 mm NaCl, 50 mm sodium phosphate, 10 mm imid-
ACHTUNGTRENNUNGazole, pH 7.9) and the proteins were eluted with elution buffer
(10% glycerol, 0.2m EDTA, pH 8.0, 0.1m NaCl, 50 mm bis-Tris,
pH 6.8). Purified ACPs were dialyzed, overnight, at 4 8C into dialysis
buffer (10% glycerol, 0.1m NaCl, 50 mm bis-Tris, pH 6.8) by using
Slide-A-Lyzer (Pierce, MWCO 3500) minidialysis units. Protein con-
centrations were determined by using the Bio-Rad Bradford pro-
tein assay with BSA as the standard. Hexanoyl-ACPs were analyzed
with electrospray mass spectrometry by using a ThermoFinni-
gan LTQ linear ion trap instrument (capillary temperature 250 8C,
capillary voltage 32 V, tube lens 95 V). Mass spectra were deconvo-
luted by using ProMassN for Xcalibur (Novatia, Princeton, USA).
Type III PKS starter unit assays : To test for substrate specificity
and determine yields, type III PKS (4 mm in 0.1m HEPES, pH 7.4)
was preincubated at 30 8C for 5 min. The reaction was started by
adding acyl-CoA (0.2 mm) and [2-14C]malonyl-CoA (0.5 mm), and
stopped after 90 min by adding concentrated hydrochloric acid
(20%, v/v). Reaction products were resolved by using TLC (silica 60
F354; Merck) with formic acid (1%) in dichloromethane/methanol
(92:8) as mobile phase. The TLC plate was exposed to a phos-
phoimager screen, overnight, alongside [2-14C]malonyl-CoA stan-
ACHTUNGTRENNUNGdards of known concentration. Radioactivity was quantified by
using ImageQuant TL v2003 software (Amersham Biosciences).
Type III PKS ACP-transfer assays : Hexanoyl-ACP primed reactions
were performed in dialysis buffer with the pH adjusted by addition
of Tris buffer, pH 8.1 (40 mm final concentration) in a total volume
of 50 mL. The reaction mixture contained type III PKS (2 mm in 0.1m
HEPES, pH 7.4), [2-14C]malonyl-CoA (80 mm), and hexanoyl-ACP
(10 mm). As negative controls, hexanoyl-ACPs were replaced with
ACP ACHTUNGTRENNUNG(Ser!Ala) mutants that had been carried through the acyla-
tion reaction as described above. Reactions that contained hexano-
yl-CoA (10 mm) were used as positive control. Samples were incu-
bated at 30 8C for 40 min, and products were extracted and ana-
lyzed by radio-TLC as described above.
Synthesis of (R,S)-N-acetylcysteaminyl-3-hydroxybutyrate (1n)
and (R)-N-acetylcysteaminyl-3-hydroxybutyrate (1o): In a typical
procedure, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC;
1.1 equiv), 4-dimethylaminopyridine (DMAP; 0.2 equiv) and SNAc
(1.1 equiv) were added to a stirred solution of 3-hydroxybutyric
acid (1 equiv) in CH2Cl2 (5 mL) at 23 8C. The reaction was stirred for
18 h and then concentrated under reduced pressure. Flash chro-
matography (silica, 2% MeOH in CH2Cl2) afforded the title com-
pounds 1n (43 mg, 21%) and 1o (136 mg, 89%) as yellow oils.
Rf=0.15 (silica, 5% MeOH in CH2Cl2) ;
1H NMR (CDCl3, 300 MHz): d=
1.24 (d, J=6.2 Hz, 3H), 1.97 (s, 3H), 2.70–2.74 (m, 2H), 3.02–3.07
(m, 2H), 3.42–3.49 (m, 2H), 4.21–4.29 (m, 1H), 5.79 ppm (br s, 1H);
MS (ESI, +ve): m/z=228.0 [M+Na]+ (C8H15NNaO3S requires 228.1).
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